YHGJ Q4 2023 Earnings Positive EPS Lifts Stock Despite Sparse Data Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher LIXT Q4 2024 Earnings PreRevenue Biotech Reports PerShare Loss as Stock Jumps 136 ANVS Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Alzheimers Pipeline Progress Keysight Technologies Q1 2026 Earnings EPS Surges Past Estimates Stock Gains TFIN Q1 2026 Earnings Strong EPS Beat Despite Limited Revenue Disclosure